Search for: "Teva Pharmaceuticals" Results 621 - 640 of 1,424
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
13 Oct 2014, 8:46 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. et al. v. [read post]
13 Oct 2014, 9:01 am by Lyle Denniston
Wednesday, the Supreme Court will hold one hour of oral argument on a high-stakes legal battle between a brand-name drug company and a group of companies making generic drugs – Teva Pharmaceuticals USA v. [read post]
9 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- Next week, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
6 Oct 2014, 5:36 am by Amy Howe
  At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
27 Sep 2014, 1:29 am by Jon Gelman
” So says the website designed to market the drug known as Nuvigil, sold by Cephalon, a subsidiary of Teva Pharmaceutical Industries, Ltd. [read post]
Teva Pharmaceuticals USA, Inc., 731 F.3d  918 (9th Cir. 2013), attorneys for many plaintiffs in 40 product liability actions filed in California state courts asked California judicial council to invoke a state rule of procedure allowing coordination of common actions for all purposes. [read post]
17 Sep 2014, 10:30 am by Maureen Johnston
This is the third installment of “Petitions to watch” featuring cases up for consideration at the Court’s September 29 “Long Conference. [read post]
8 Sep 2014, 4:55 am
According to the publisher Edward Elgar, the book “illustrates the crucial role that patent strategies play within processes of pharmaceutical innovation”  by “drawing on extensive country and company case studies” from the United States, Japan, South Korea and Israel and identifying “the key issues relevant to the revival of local pharmaceutical industries”. [read post]
3 Sep 2014, 3:19 pm
The heart of the book is a 49-page description and subsequent analysis and comparison of the experience of four countries -- the United States, Japan, South Korea and Israel -- followed by a 36-page in-depth study of the experiences of leading Israeli pharmaceutical company Teva. [read post]
28 Aug 2014, 7:42 am by Brenda Fulmer
  If generic drug manufacturers will not be held liable for the harm they inflict on patients, then we should not be forced by our government and health insurers to ingest their generic pharmaceuticals. [read post]
25 Aug 2014, 8:57 am
 This patent infringement action was in respect of Takeda's US Patent No 7,339,064 (the "064 Patent") which claims crystalline forms of benximidazole derivatives in a pharmaceutical composition for treating and preventing digestive ulcers. [read post]
15 Aug 2014, 7:08 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 1-12-cv-08060 (NYSD August 13, 2014, Order) (Griesa, J.) [read post]
11 Aug 2014, 4:11 pm by Lawrence B. Ebert
Teva Pharmaceutical Industries intends to file a Hatch-Waxman infringement law suit against Dr Reddy's Laboratories related to Reddy's paragraph IV filing as to the patents of Copaxone (glatiramer acetate) injection 40mg/mL.link: http://economictimes.indiatimes.com/articleshow/40058561.cms? [read post]
7 Aug 2014, 6:25 am by Stacy
The Supreme Court has recently agreed to hear the case of Teva Pharmaceuticals v. [read post]
6 Aug 2014, 7:10 pm by Maureen Johnston
Teva Pharmaceuticals USA, Inc. 13-1251 Issue: Whether the statutory bar for “public use” of an invention under 35 U.S.C. [read post]
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
27 Jul 2014, 9:38 pm by Patent Docs
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]